CT
PFE icon

Caldwell Trust’s Pfizer PFE Stock Holding History

Caldwell Trust’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.26M Sell
44,984
-361
-0.8% -$9.61K 0.11% 146
2025
Q4 		$1.13M Sell
45,345
-5,238
-10% -$132K 0.1% 154
2025
Q3 		$1.29M Sell
50,583
-2,029
-4% -$50.1K 0.12% 148
2025
Q2 		$1.28M Sell
52,612
-1,293
-2% -$30.2K 0.13% 143
2025
Q1 		$1.37M Sell
53,905
-2,371
-4% -$62K 0.15% 135
2024
Q4 		$1.49M Sell
56,276
-3,998
-7% -$108K 0.16% 123
2024
Q3 		$1.74M Sell
60,274
-4,052
-6% -$118K 0.18% 113
2024
Q2 		$1.8M Sell
64,326
-9,789
-13% -$270K 0.2% 100
2024
Q1 		$2.06M Sell
74,115
-13,435
-15% -$373K 0.24% 94
2023
Q4 		$2.52M Sell
87,550
-14,379
-14% -$435K 0.32% 71
2023
Q3 		$3.38M Sell
101,929
-4,935
-5% -$175K 0.46% 51
2023
Q2 		$3.92M Sell
106,864
-4,609
-4% -$179K 0.51% 49
2023
Q1 		$4.55M Sell
111,473
-1,407
-1% -$60.8K 0.63% 44
2022
Q4 		$5.78M Buy
112,880
+2,662
+2% +$128K 0.82% 37
2022
Q3 		$4.82M Sell
110,218
-87
-0.1% -$4.23K 0.72% 40
2022
Q2 		$5.78M Buy
110,305
+413
+0.4% +$21K 0.8% 36
2022
Q1 		$5.69M Sell
109,892
-196
-0.2% -$10.2K 0.68% 38
2021
Q4 		$6.5M Sell
110,088
-417
-0.4% -$20.7K 0.75% 34
2021
Q3 		$4.75M Buy
110,505
+20,880
+23% +$925K 0.6% 41
2021
Q2 		$3.51M Buy
89,625
+7,581
+9% +$295K 0.46% 53
2021
Q1 		$2.97M Buy
82,044
+6,786
+9% +$241K 0.41% 59
2020
Q4 		$2.77M Sell
75,258
-3,379
-4% -$124K 0.42% 57
2020
Q3 		$2.74M Sell
78,637
-216
-0.3% -$7.57K 0.45% 55
2020
Q2 		$2.45M Sell
78,853
-2,753
-3% -$93.5K 0.41% 61
2020
Q1 		$2.53M Sell
81,606
-1,287
-2% -$43.9K 0.48% 57
2019
Q4 		$3.08M Buy
+82,893
New +$2.95M 0.47% 62

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Caldwell Trust's PFE Position: Q1 2026 in Review

Caldwell Trust reduced its Pfizer (PFE) stake by 0.8% in Q1 2026, selling an estimated $9.61K and leaving 44,984 shares worth $1.26M. The position accounts for 0.11% of the portfolio, ranked #146.

Caldwell Trust first reported a position in PFE in Q4 2019 and has held it in 26 quarters since. The position peaked at $6.5M in Q4 2021. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Caldwell Trust held 44,984 shares of Pfizer worth $1.26M as of Q1 2026.
  • Caldwell Trust sold 361 Pfizer shares in Q1 2026, an estimated $9.61K.
  • Pfizer made up 0.11% of Caldwell Trust's portfolio in Q1 2026, its #146 holding.
  • Caldwell Trust first reported a position in Pfizer in Q4 2019 and has held it in 26 quarters since.
  • Caldwell Trust's Pfizer position peaked at $6.5M in Q4 2021.
  • 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Caldwell Trust's 13F filing for Q1 2026, filed 22 Apr 2026.